Are Cladribine and Rituximab Enough for the Treatment of Relapsed Hairy Cell Leukemia?
<p><strong></strong><strong>Introduction:</strong> Hairy cell leukemia is a rare B-cell lymph proliferation with long-term survivals, in general. Although therapeutic possibilities have progressed over time, many patients have recurrences and the disease can become resi...
Saved in:
Main Author: | Romeo-Gabriel Mihaila (Author) |
---|---|
Format: | Book |
Published: |
International Journal of Immunotherapy and Cancer Research - Peertechz Publications,
2015-08-14.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
T-Cell Leukemia Characteristics, Treatment and Prevention
Published: (2013) -
T-Cell Leukemia
Published: (2011) -
Novel Strategies to Improve Rituximab Efficacy in Non-Hodgkin's Lymphomas
by: Massimo Bortolotti, et al.
Published: (2015) -
Advance in the Treatment of Pediatric Leukemia
Published: (2022) -
A Very Rare Case of Polycythemia Vera Patient Who Developed Other Four Cancers
by: Romeo-Gabriel Mihaila
Published: (2017)